Table 2.
Univariate analysis of clinical data.
| Non-ESBL | ESBL | p-Value * | |
|---|---|---|---|
| Cystitis | 17 (15.2%) | 23 (37.7%) | 0.001 |
| Pyelonephritis | 39 (34.8%) | 12 (19.7%) | 0.038 |
| Confusion syndrome associated with UTIs | 34 (30.4%) | 21 (34.4%) | 0.611 |
| Prostatitis | 6 (5.4%) | 2 (3.3%) | 0.714 |
| Sepsis | 40 (35.7%) | 12 (19.7%) | 0.037 |
| Shock | 6 (5.4%) | 0 (0%) | 0.091 |
| Positive blood culture | 45 (40.2%) | 13 (21.3%) | 0.012 |
| Infectious diseases intervention | 32 (28.6%) | 43 (70.5%) | <0.001 |
| Pharmacy intervention | 9 (8%) | 13 (21.3%) | 0.017 |
| Appropriate empirical treatment | 104 (92.9%) | 23 (37.7%) | <0.001 |
| Time to adequate treatment (days) | 0.54 ± 1.4 | 1.59 ± 2.1 | <0.001 |
| Duration of hospital treatment (days) | 4.57 ± 2.64 | 4.06 ± 4.1 | 0.956 |
| Clinical response at seven days | 82 (73.2%) | 31 (50.8%) | 0.004 |
| Days of hospitalization | 8.43 ± 6.42 | 11.62 ± 7.1 | 0.003 |
| Readmission for the same UTI | 24 (21.4%) | 17 (27.9%) | 0.355 |
| Emergency consultation a | 25 (22.3%) | 18 (29.5%) | 0.358 |
| Home hospitalization | 5 (4.5%) | 10 (16.4%) | 0.011 |
| ICU admission | 6 (5.4%) | 0 (0%) | 0.091 |
| Mortality within 30 days | 12 (10.7%) | 3 (4.9%) | 0.263 |
a Re-consultation in the emergency room within 30 days after discharge; * Student’s t-test or Mann–Whitney U was used for comparing quantitative variables. The Chi-square test was used for comparing qualitative variables. ESBL: extended spectrum betalactamases; ICU: intensive care unit.